Uveal Melanoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
Conditions:   Melanoma;   Melanoma, Uveal;   Head and Neck Cancer Intervention:   Biological: Adoptive therapy with autologous MC2 TCR T cells Sponsors:   Erasmus Medical Center;   Ludwig Institute for Cancer Research;   Dutch Cancer Society;   Stichting Coolsingel Rotterdam grant;   Jan Ivo Stichting grant Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2021 Category: Research Source Type: clinical trials

Defactinib (VS-6063) Combined With VS-6766 in Patients With Metastatic Uveal Melanoma
Condition:   Uveal Melanoma Interventions:   Drug: VS-6063;   Drug: VS-6766 Sponsors:   Thomas Jefferson University;   Verastem, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials